Understanding Chronic Lymphocytic Leukemia
概览
- 阶段
- 不适用
- 干预措施
- Sample Collection
- 疾病 / 适应症
- Chronic Lymphocytic Leukemia
- 发起方
- Dana-Farber Cancer Institute
- 入组人数
- 2750
- 试验地点
- 2
- 主要终点
- Incidence of novel genomic prognostic markers in Chronic Lymphocytic Leukemia
- 状态
- 招募中
- 最后更新
- 8天前
概览
简要总结
The purpose of this study is to collect human Chronic Lymphocytic Leukemia tissue samples and medical information, in order to find out more about the causes and biology of chronic lymphocytic leukemia.
详细描述
The purpose of this study is to collect human Chronic Lymphocytic Leukemia tissue samples and medical information, in order to find out more about the causes and biology of chronic lymphocytic leukemia, for the potential development of more effective therapies for this disease.
研究者
Jennifer R. Brown, MD, PhD
Principal Investigator
Dana-Farber Cancer Institute
入排标准
入选标准
- •New and existing patients seen for treatment of monoclonal B-cell lymphocytosis
- •Any low grade lymphoproliferative disorder
- •Chronic Lymphocytic Leukemia in the Dana Farber Cancer Institute Hematologic Oncology Clinic or elsewhere
排除标准
- 未提供
研究组 & 干预措施
Sample Collection
* Blood tests required for assessment * Specimens and data will also be collected from outside sites * Clinical data from patients with Chronic Lymphocytic Leukemia will be gathered into a database at Dana Farber Cancer Institute
结局指标
主要结局
Incidence of novel genomic prognostic markers in Chronic Lymphocytic Leukemia
时间窗: 20 years
Exploratory science to better understand Chronic Lymphocytic Leukemia